Partnership Focus
Our unique oral drug delivery technology is of critical interest to Big Pharma as a means to enhance their product portfolios
- Pursuit of most realistic indications
- Focus on clinical proof-of-concept
- Structure deals as a vehicle to maintain strong balance sheet
- Seek fast ROI through creation of earlier partnerships prior to initiation of large scale studies
- Partners to fund, control and monitor late-stage product development and commercialization